Home
>
National Drug Code (NDC)
>
INVOKANA
INVOKANA - 50458-141-90 - (canagliflozin)
Drug Information of INVOKANA
| Product NDC: | 50458-141 |
| Proprietary Name: | INVOKANA |
| Non Proprietary Name: | canagliflozin |
| Active Ingredient(s): | 300 mg/1 & nbsp; canagliflozin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of INVOKANA
| Product NDC: | 50458-141 |
| Labeler Name: | Janssen Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA204042 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20130329 |
Package Information of INVOKANA
| Package NDC: | 50458-141-90 |
| Package Description: | 90 TABLET, FILM COATED in 1 BOTTLE (50458-141-90) |
NDC Information of INVOKANA
| NDC Code | 50458-141-90 |
| Proprietary Name | INVOKANA |
| Package Description | 90 TABLET, FILM COATED in 1 BOTTLE (50458-141-90) |
| Product NDC | 50458-141 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | canagliflozin |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20130329 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Pharmaceuticals, Inc. |
| Substance Name | CANAGLIFLOZIN |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
